Back to Journals » Journal of Hepatocellular Carcinoma » Volume 2

Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Total article views   HTML views PDF downloads Totals
9,955 Dovepress* 9,495+ 1,036 10,531
PubMed Central* 460 69 529
Totals 9,955 1,105 11,060
*Since 22 June 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar